tariquidar has been researched along with midazolam in 2 studies
| Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies (midazolam) | Trials (midazolam) | Recent Studies (post-2010) (midazolam) |
|---|---|---|---|---|---|
| 210 | 16 | 138 | 9,834 | 3,191 | 3,301 |
| Protein | Taxonomy | tariquidar (IC50) | midazolam (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 2.7427 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurnik, D; Wilkinson, GR; Wood, AJ | 1 |
| da Costa César, I; de Araújo, LL; de Castro, WV; de Lima Nascimento, M; de Oliveira, FM; Derendorf, H; do Carmo Vieira, M; do Nascimento, SB; Duarte-Almeida, JM; Siqueira, JM | 1 |
1 trial(s) available for tariquidar and midazolam
| Article | Year |
|---|---|
The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity.
Topics: Adult; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breath Tests; Cross-Over Studies; Cytochrome P-450 CYP3A; Double-Blind Method; Enzyme Inhibitors; Erythromycin; GABA Modulators; Humans; Infusions, Intravenous; Injections, Intravenous; Liver; Male; Metabolic Clearance Rate; Midazolam; Quinolines; Reproducibility of Results; Time Factors | 2006 |
1 other study(ies) available for tariquidar and midazolam
| Article | Year |
|---|---|
Evaluation of the Effects of Maytenus ilicifolia on the Activities of Cytochrome P450 3A and P-glycoprotein.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cell Line; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Ketoconazole; Male; Maytenus; Midazolam; Plant Extracts; Quinolines; Rats; Rats, Wistar; Terfenadine | 2020 |